Yantai Zhenghai Bio-tech, a Chinese biotechnology company backed by CDH Investments, saw its stock gain 44.03% on its first day of trading following a RMB234 million ($34 million) IPO in Shenzhen.
Zhenghai Bio-tech sold 20 million shares at RMB11.72 apiece. CDH - which invested $233,333 for a 12% stake in the company in 2015 - did not make a partial exit in the offering. The stock opened at RMB15.47...
Cathay Capital Private Equity has reached a first close of EUR600 million ($702 million) for its latest middle-market Sino-European fund. The target is EUR1.2 billion.
Opera Software, a Norwegian web browser developer acquired by a PE-backed Chinese consortium in 2016, is looking to raise up to $115.2 million in a US IPO.
51 Credit Card, a Chinese online credit card management platform backed by the likes of Tiantu Capital, GGV Capital, and Shunwei Capital, raised HK$1 billion ($128.5 million) in its Hong Kong IPO.
Singapore’s Golden Equator Capital and Korea Investment Partners (KIP) have jointly launched a S$120 million ($88 million) Southeast Asia technology fund focused on start-ups and small to medium-sized enterprises (SME).